drugset / Trial / NCT03720223
Liposomal Bupivacaine To Control Post-Operative Pain Following BMG
RandomizedParallel-groupTriple-blindTreatment
Summary
This is a single blinded-randomized controlled trial that recruit male patients for substitution urethroplasty using buccal mucosal graft. The study investigators aim to assess the efficacy and safety of liposomal bupivacaine injection to the buccal graft harvest site on post-operative main score, morphine equivalence requirement and oral morbidities.
Timeline
- Start
- 2015-01-20
- Primary completion
- 2017-10-31
- Completion
- 2017-10-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Bupivacaine | Other / unclassified | 1.3 % | Other |
| Subject | Bupivacaine | Other / unclassified | 13.3 mg/ml | Other |
| Subject | Bupivacaine | Other / unclassified | 20 ml | Other |